In order to promote academic exchanges and experience sharing of standardized diagnosis and treatment of esophageal cancer, promote the standardization and standardization of diagnosis and treatment of esophageal cancer in my country, and gradually realize standardization, specialization, standardization, refinement and informationization, and ultimately benefit the majority of patients. On April 10, 2022, the second session of the esophageal cancer standardized diagnosis and treatment exchange-youth college project hosted by the Chengdu High-tech Medical Association was successfully held in Xi'an. Exchange and interactive discussions to improve the diagnosis and treatment level of young doctors and continue to learn.

The meeting was opened and summarized by Prof. Jiang Tao and Prof. Ni Yunfeng from Tangdu Hospital of Air Force Military Medical University. Prof. Leng Xuefeng from Sichuan Cancer Hospital focused on the interpretation of "Hot Spots in Esophageal Surgery"; Prof. Du Ning and Prof. Liu Rui from the First Affiliated Hospital of Xi'an Jiaotong University shared their views on "Esophageal Cancer Immunotherapy from the Progress of 2022 ASCO-GI". "Present and Future" - Bureau Evening Chapter" and "The "Present and Future" of Esophageal Cancer Immunotherapy from 2022 ASCO-GI Progress - Bureau Evening Chapter"; Professor Zhao Jinbo, Professor Xue Menghua and Professor Zhu Jianfei from Tangdu Hospital of Air Force Military Medical University The esophageal cancer immunization case was shared and explained; according to the teaching content of the participating experts, all the professors launched a stimulating discussion.

This conference provides a platform for clinical doctors and scientific researchers to exchange diagnosis and treatment technology and academic research results, which is conducive to academic discussions and exchanges of classic cases and cutting-edge technologies in the promotion of tumor immunity, and establishes comprehensive and standardized treatment of oncology medicine. concept. It is of great significance to promote high-quality clinical research in the field of medical oncology and promote the level of clinical scientific research.